Review
Open access
Oct 2026
From RNA fate to cancer state transitions: m5C-driven metabolic and immune reprogramming (Review)
Clinical translation requires relating treatment-induced RNA changes to drug exposure, tumor selectivity and immune-cell function, rather than relying on regulator expression alone.
Yuan-Li Zhou, Bolv Zhu, Xin Tang et al.
· International Journal of Mol... · 0 citations